Patents by Inventor Jeff Gilmore

Jeff Gilmore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10335432
    Abstract: The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects. The preferred formulations are designed avoid increase in pH of urine in patients and/or avoid potential entry of particles into the bloodstream of the patient. Also disclosed is a method for preparing high purity crystals of UZSi-9 exhibiting an enhanced level of potassium exchange capacity. These compositions are particularly useful in the therapeutic treatment of hyperkalemia.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: July 2, 2019
    Assignee: ZS PHARMA, INC.
    Inventors: Donald Jeffrey Keyser, Alvaro F. Guillem, Jeff Gilmore
  • Publication number: 20160367598
    Abstract: The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects. The preferred formulations are designed avoid increase in pH of urine in patients and/or avoid potential entry of particles into the bloodstream of the patient. Also disclosed is a method for preparing high purity crystals of UZSi-9 exhibiting an enhanced level of potassium exchange capacity. These compositions are particularly useful in the therapeutic treatment of hyperkalemia.
    Type: Application
    Filed: September 1, 2016
    Publication date: December 22, 2016
    Inventors: Donald Jeffrey KEYSER, Alvaro F. GUILLEM, Jeff GILMORE
  • Patent number: 9457050
    Abstract: The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects. The preferred formulations are designed avoid increase in pH of urine in patients and/or avoid potential entry of particles into the bloodstream of the patient. Also disclosed is a method for preparing high purity crystals of UZSi-9 exhibiting an enhanced level of potassium exchange capacity. These compositions are particularly useful in the therapeutic treatment of hyperkalemia.
    Type: Grant
    Filed: March 26, 2014
    Date of Patent: October 4, 2016
    Assignee: ZS Pharma, Inc.
    Inventors: Donald Jeffrey Keyser, Alvaro F. Guillem, Jeff Gilmore
  • Patent number: 9095825
    Abstract: Fluid injection system for dispensing a solution into a fluid flow in a flow line, the fluid injection system including a storage tank having product to be dispensed therein; an inlet connection diverting fluid from the flow line into the tank; an outlet connection returning a mixture of fluid/product back into the flow line; a metering gauge in fluid communication with the inlet connection measuring water flowing into the tank; and a tank head connected to the storage tank and having multiple ports for connection to the inlet connection depending on whether the product to be dispensed is in liquid dry form. The inlet connection includes an inlet probe having an opening defined by an arc at a downstream side. The outlet connection includes an outlet probe having an opening having an angled cut facing downstream, such that a pressure differential is created between the inlet and outlet probes.
    Type: Grant
    Filed: November 6, 2013
    Date of Patent: August 4, 2015
    Assignee: EZ-FLO Injection Systems, Inc.
    Inventors: Dan Gilmore, Jeff Gilmore
  • Publication number: 20140287060
    Abstract: The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects. The preferred formulations are designed avoid increase in pH of urine in patients and/or avoid potential entry of particles into the bloodstream of the patient. Also disclosed is a method for preparing high purity crystals of UZSi-9 exhibiting an enhanced level of potassium exchange capacity. These compositions are particularly useful in the therapeutic treatment of hyperkalemia.
    Type: Application
    Filed: March 26, 2014
    Publication date: September 25, 2014
    Inventors: Donald Jeffrey KEYSER, Alvaro F. Guillem, Jeff Gilmore
  • Publication number: 20140124045
    Abstract: A fluid injection system for dispensing a solution into a fluid flow in a flow line, the fluid injection system including a storage tank having product to be dispensed therein; an inlet connection diverting fluid from the flow line into the tank; an outlet connection returning a mixture of fluid/product back into the flow line; a metering gauge in fluid communication with the inlet connection measuring water flowing into the tank; and a metering head connected to the storage tank and having multiple ports for connection to the inlet connection depending on whether the product to be dispensed is in liquid dry form. The inlet connection includes an inlet probe having an opening defined by an arc at a downstream side. The outlet connection includes an outlet probe having an opening having an angled cut facing downstream, such that a pressure differential is created between the inlet and outlet probes.
    Type: Application
    Filed: November 6, 2013
    Publication date: May 8, 2014
    Applicant: EZ-FLO Injection Systems, Inc.
    Inventors: Dan Gilmore, Jeff Gilmore